<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-145-389</article-id>
<article-id pub-id-type="doi">10.26800/LV-145-11-12-8</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group>
</article-categories>
<title-group>
<article-title>Uloga klini&#x010D;kih smjernica u pobolj&#x0161;anju zdravstvene za&#x0161;tite</article-title>
<trans-title-group xml:lang="en">
<trans-title>The role of clinical practice guidelines in advancing healthcare</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mi&#x010D;eti&#x0107;</surname><given-names>Domagoj</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>&#x0160;timac</surname><given-names>Davor</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<aff id="aff1"><label>1</label>Klini&#x010D;ki bolni&#x010D;ki centar Rijeka</aff>
<aff id="aff2"><label>2</label>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Rijeci</aff>
<aff id="aff3"><label>3</label>Specijalna bolnica Medico</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Adresa za dopisivanje: Prof. dr. sc. Davor &#x0160;timac, dr. med., Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Rijeci, Specijalna bolnica Medico, e-po&#x0161;ta: <email xlink:href="davor.stimac@medri.uniri.hr">davor.stimac@medri.uniri.hr</email></corresp>
<fn fn-type="con">
<p content-type="fn-title">DOPRINOS AUTORA</p>
<p>K<sc>oncepcija</sc> <sc>ili</sc> <sc>nacrt</sc> <sc>rada</sc>: DM, D&#x0160;</p>
<p>P<sc>rikupljanje</sc>, <sc>analiza</sc> <sc>i</sc> <sc>interpretacija</sc> <sc>podataka</sc>: DM, D&#x0160;</p>
<p>P<sc>isanje</sc> <sc>prve</sc> <sc>verzije</sc> <sc>rada</sc>: DM</p>
<p>K<sc>riti&#x010D;ka</sc> <sc>revizija</sc>: D&#x0160;</p>
</fn>
</author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>01</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>01</month><year>2024</year></pub-date>
<volume>145</volume>
<issue>11-12</issue>
<fpage>389</fpage>
<lpage>392</lpage>
<permissions>
<copyright-statement>Croatian Medical Association</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Klini&#x010D;ke smjernice donose preporuke za rad klini&#x010D;ara koje proizlaze iz sustavnog pregleda dokaza. Cilj rada je opisati njihov povijesni razvoj, ukazati na prednosti koje donose, ali i potencijalne nedostatke. Prve smjernice objavljene su u &#x0161;ezdesetim godinama pro&#x0161;log stolje&#x0107;a, a zbog primjenjivosti njihov broj nastavlja rasti. Prednosti koje donose uklju&#x010D;uju ujedna&#x010D;avanje zdravstvene skrbi, &#x0161;to rezultira pobolj&#x0161;anjem klini&#x010D;kih ishoda. Samim time napu&#x0161;taju se neu&#x010D;inkovite metode. Tako&#x0111;er, bolesnici u smjernicama nalaze informacije o tome &#x0161;to je za njih optimalno te su smjernice na&#x010D;in osna&#x017E;ivanja polo&#x017E;aja bolesnika. Navedeno mo&#x017E;e rezultirati boljom u&#x010D;inkovitosti zdravstvenog sustava. Klini&#x010D;ke smjernice imaju i svoje nedostatke. Neka pitanja nemaju odgovore u rezultatima istra&#x017E;ivanja koji se nalaze visoko u hijerarhiji dokaza, ve&#x0107; su rezultat mi&#x0161;ljenja stru&#x010D;njaka, koji mogu biti u krivu. Ponekad zbog inkonkluzivnih rezultata istra&#x017E;ivanja preporuke isto tako mogu biti dvosmislene. Zbog brzog priljeva novih dokaza preporuke u smjernicama mogu biti zastarjele. Premda su razvijeni protokoli, ostavlja se mogu&#x0107;nost sukoba interesa autora kao i pristranosti zbog izvora financiranja istra&#x017E;ivanja. Klini&#x010D;ke smjernice unaprijedile su zdravstvenu skrb i zaslu&#x017E;ne su za pobolj&#x0161;anje ishoda bolesnika. No, prilikom dono&#x0161;enja kona&#x010D;ne odluke o pristupu pojedinom bolesniku valja uzeti u obzir i vrijednosti bolesnika kao i procjenu klini&#x010D;ara, &#x0161;to je u skladu s na&#x010D;elima medicine temeljene na dokazima.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>Clinical guidelines provide recommendations for healthcare professionals based on a systematic review of evidence. The aim of this paper is to describe their historical development, highlight the benefits they bring, but also potential drawbacks. The first guidelines were published in the 1960s, and due to their applicability, their number continues to grow. The advantages they offer include standardizing healthcare, resulting in improved clinical outcomes. In this way, inefficient methods are abandoned. Additionally, patients can find information in guidelines about what is optimal for them, and guidelines empower the position of patients. This can lead to better healthcare system efficiency. However, clinical guidelines also have their disadvantages. Some questions do not have answers in the high quality evidence, but instead rely on expert opinions, which can be incorrect. Sometimes, due to inconclusive research results, recommendations can also be ambiguous. Because of the rapid influx of new evidence, recommendations in guidelines can become outdated. Although protocols have been developed, there is still the possibility of conflicts of interest among authors and bias due to research funding sources. Clinical guidelines have improved healthcare and are responsible for enhancing patient outcomes. However, to make a final decision about an individual patient&#x2019;s approach, one should also consider patient values and the clinical judgment assessment, which is in line with evidence-based medicine principles.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori SMJERNICE &#x2013; standardi</kwd><kwd>MEDICINA TEMELJENA NA DOKAZIMA &#x2013; standardi</kwd><kwd>KLINI&#x010C;KO ODLU&#x010C;IVANJE</kwd><kwd>PRISTRANOST</kwd><kwd>KVALITETA ZDRAVSTVENE SKRBI</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>PRACTICE GUIDELINES AS TOPIC &#x2013; standards</kwd><kwd>EVIDENCE-BASED PRACTICE &#x2013; standards</kwd><kwd>CLINICAL DECISION MAKING</kwd><kwd>BIAS</kwd><kwd>QUALITY OF HEALTH CARE</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Klini&#x010D;ke smjernice definiraju se kao &#x201E;izjave koje uklju&#x010D;uju preporuke namijenjene unaprje&#x0111;enju skrbi za pacijente koje se temelje na sustavnom pregledu dokaza i procjeni koristi i &#x0161;teta alternativnih mogu&#x0107;nosti skrbi&#x201C;. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Nije poznat to&#x010D;an broj trenutno va&#x017E;e&#x0107;ih smjernica, no mo&#x017E;emo govoriti o trendu porasta broja nama dostupnih. Uzimaju&#x0107;i u obzir podatke za &#x0160;vedsku, broj objavljenih nacionalnih klini&#x010D;kih smjernica 2005. godine iznosio je 40, pet godina kasnije brojka je porasla skoro za 50%. Posljednji dostupni podatci govore kako je 2018. godine objavljeno vi&#x0161;e od 160 nacionalnih klini&#x010D;kih smjernica. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Usporedbu mo&#x017E;emo u&#x010D;initi s nekim drugim trendovima. Primjerice u izdava&#x0161;tvu, najve&#x0107;i rast se prati u broju objavljenih audioknjiga. Njihov broj je porastao od 6.200 knjiga objavljenih 2010. godine na 74.000 koje su objavljene 2021. godine u Sjedinjenim Ameri&#x010D;kim Dr&#x017E;avama. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) U znanstvenim krugovima prati se porast udjela radova koji govore o umjetnoj inteligenciji. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>)</p>
<p>Ono &#x0161;to je tra&#x017E;eno donosi o&#x010D;itu korist, a kada govorimo o smjernicama moglo bi se re&#x0107;i kako one sa&#x017E;imaju dokaze i kreiraju preporuke za rad klini&#x010D;ara. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Cilj je ovoga preglednog rada objasniti evoluciju razvoja smjernica, njihov metodolo&#x0161;ki put te navesti prednosti koje donose u svakodnevnom radu. Tako&#x0111;er, navedeni su i mogu&#x0107;i nedostatci kako bi prikaz bio cjelovit.</p>
<sec sec-type="other1">
<title>Povijest klini&#x010D;kih smjernica</title>
<p>Po&#x010D;etci se vezuju za &#x0161;ezdesete i sedamdesete godine pro&#x0161;log stolje&#x0107;a kada su Ameri&#x010D;ko dru&#x0161;tvo lije&#x010D;nika (engl. <italic>American College of Physicians</italic>) i Ameri&#x010D;ka medicinska organizacija (engl. <italic>American Medical Association</italic>) objavili prve medicinske smjernice, dokumente &#x010D;iji je cilj bio ujedna&#x010D;avanje pristupa i unaprje&#x0111;ivanje ishoda lije&#x010D;enja bolesnika. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) Idu&#x0107;a dva desetlje&#x0107;a obilje&#x017E;io je okret od medicine temeljene na mi&#x0161;ljenju (engl. <italic>opinion based medicine</italic>) k medicini temeljenoj na dokazima (engl. <italic>evidence based medicine</italic>). (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Navedeno razdoblje je obilje&#x017E;eno kreiranjem piramide hijerarhije dokaza, sustava vrjednovanja dokaza i sustavnih pregleda radova. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) Po&#x010D;etak novog tisu&#x0107;lje&#x0107;a donio je bolju me&#x0111;unarodnu povezanost u dono&#x0161;enju smjernica uz daljnje unaprje&#x0111;enje i stavljanje naglaska na metodologiju, transparentnost i sustavno vrjednovanje dokaza. Drugo desetlje&#x0107;e novog stolje&#x0107;a donijelo je unaprje&#x0111;enje na dva podru&#x010D;ja. Naglasak se stavlja na pacijenta koji je u sredi&#x0161;tu, poti&#x010D;e se zajedni&#x010D;ko dono&#x0161;enje odluka koje su u skladu s bolesnikovim uvjerenjima i o&#x010D;ekivanjima, a digitalizacija dru&#x0161;tva omogu&#x0107;ila je bolju dostupnost smjernica lije&#x010D;nicima te je na taj na&#x010D;in olak&#x0161;ana njihova implementacija u svakodnevnu klini&#x010D;ku praksu. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>, <xref ref-type="bibr" rid="r10"><italic>10</italic></xref>)</p>
</sec>
<sec sec-type="other2">
<title>Put do objave klini&#x010D;kih smjernica</title>
<p>Kreiranje klini&#x010D;kih smjernica uklju&#x010D;uje sustavan rad utemeljen na dokazima koji osigurava pouzdanost, relevantnost i ostvarivost iznesenih preporuka. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) Premda se koraci mogu pone&#x0161;to razlikovati me&#x0111;u organizacijama i ovisno o tematici, temeljni princip je podjednak. Prvi korak uklju&#x010D;uje formiranje multidisciplinarnog tima, radne skupine za kreiranje smjernica. Grupa uklju&#x010D;uje klini&#x010D;are, bazi&#x010D;ne istra&#x017E;iva&#x010D;e, metodi&#x010D;are, ali i predstavnike pacijenata kako bi se osigurala sveobuhvatnost. Formirana grupa mora postaviti opseg i ciljeve smjernica kojima &#x0107;e se baviti. Slijedi sveobuhvatni pregled literature kako bi se prona&#x0161;li i evaluirali postoje&#x0107;i dokazi povezani s temom, a informacije se uzimaju u obzir ako zadovoljavaju prethodno definirane uklju&#x010D;ne kriterije, a nema podudarnosti s isklju&#x010D;nim kriterijima. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) Kvaliteta prikupljenih informacija provjerava se kori&#x0161;tenjem standardiziranih alata za procjenu rizika od pristranosti i metodolo&#x0161;ke strogo&#x0107;e. Temeljem prikupljenih &#x010D;injenica kreiraju se preporuke za klini&#x010D;ku praksu, a svaka iznesena preporuka trebala bi biti ocijenjena snagom podupiru&#x0107;ih dokaza pomo&#x0107;u standardiziranih sustava ocjenjivanja (npr. GRADE, engl. <italic>Grading of Recommendations, Assessment, Development, and Evaluations</italic>). (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>, <xref ref-type="bibr" rid="r12">12</xref>) U proces izrade smjernica uklju&#x010D;eni su predstavnici pacijenata kako bi se omogu&#x0107;ilo uva&#x017E;avanje vrijednosti i iskustva onih zbog kojih se smjernice i kreiraju. Jednom kreiran nacrt smjernica dijeli se s vanjskim stru&#x010D;njacima, organizacijama ili interesnim skupinama kako bi se prikupile relevantne informacije s ciljem unaprje&#x0111;enja smjernica. Temeljem dobivenih informacija revidiraju se i finaliziraju preporuke kako bi bile jasne, specifi&#x010D;ne i prakti&#x010D;ne za provedbu. Posljednji korak je njihova objava u specijaliziranim &#x010D;asopisima i na mre&#x017E;nim stranicama stru&#x010D;nih dru&#x0161;tava. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) Va&#x017E;an korak koji doprinosi relevantnosti smjernica jest otkrivanje potencijalnih sukoba interesa autora. Transparentnost, pridr&#x017E;avanje pravila o pisanju i suradnja klju&#x010D;ni su za izradu visokokvalitetnih smjernica koje se temelje na dokazima, usmjerene su na pacijenta i relevantne za klini&#x010D;ku praksu. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>)</p>
</sec>
<sec sec-type="other3">
<title>Koje prednosti nam donose klini&#x010D;ke smjernice?</title>
<p>Desetlje&#x0107;ima su unaprje&#x0111;ivane, a put od ideje do njihove objave je slo&#x017E;en, a sve se radi s ciljem kreiranja jasnih preporuka. Klini&#x010D;ke smjernice nastaju iz potrebe (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>) za ujedna&#x010D;avanjem zdravstvene skrbi u okolnostima rastu&#x0107;ih tro&#x0161;kova u zdravstvu do kojih dolazi pristizanjem novih lijekova, dijagnosti&#x010D;kih i terapijskih mogu&#x0107;nosti te pove&#x0107;anjem broja bolesnika uslijed starenja populacije. Tako&#x0111;er, postoji lije&#x010D;ni&#x010D;ki poriv za pru&#x017E;anjem najbolje mogu&#x0107;e usluge, a s druge strane bolesnikova o&#x010D;ekivanja o primanju iste takve skrbi. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Postoje dokazi kako klini&#x010D;ke smjernice mogu pobolj&#x0161;ati klini&#x010D;ke ishode, a kao glavni razlog nepostizanja rezultata istra&#x017E;ivanja u praksi navodi se nepridr&#x017E;avanje posljednjih dostupnih preporuka. (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>, <xref ref-type="bibr" rid="r17"><italic>17</italic></xref>)</p>
<p>Prednosti koje donose klini&#x010D;ke smjernice odnose se na ujedna&#x010D;avanje pru&#x017E;ene usluge koja svoje upori&#x0161;te ima u raspolo&#x017E;ivim dokazima. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>) Prakticiraju&#x0107;i ono &#x0161;to je preporu&#x010D;eno, automatski se odmi&#x010D;e od prakse suboptimalnih rje&#x0161;enja. Kako su smjernice javno dostupne, one slu&#x017E;e i osna&#x017E;ivanju bolesnika koji u njima tra&#x017E;e rje&#x0161;enje svojih problema. Nadalje, slijede&#x0107;i preporuke klini&#x010D;ar se mo&#x017E;e za&#x0161;titi od nepovoljnog ishoda u pravnim sporovima. Objavljivanjem smjernica detektiraju se i pitanja na koja nemamo odgovore te se na taj na&#x010D;in usmjeravaju znanstvenoistra&#x017E;iva&#x010D;ki napori k pronala&#x017E;enju potrebnih odgovora. Smjernice utje&#x010D;u na javnu politiku. Zbog njihova postojanja neke metode/lijekovi mogu postati dostupni, primjerice u sredinama gdje ranije nisu bili. Financijska sredstva mogu se usmjeriti na ono &#x0161;to je po&#x017E;eljno, a isto tako se mogu oduzeti od onoga &#x0161;to ne bi trebalo biti prakticirano. Pridr&#x017E;avanje smjernica mo&#x017E;e kroz standardizaciju skrbi doprinijeti boljoj u&#x010D;inkovitosti sustava smanjuju&#x0107;i broj nepotrebnih pretraga i zahvata. Tako&#x0111;er, rad u skladu sa smjernicama percipira se u javnosti kao stremljenje k izvrsnosti, &#x0161;to doprinosi ugledu ustanove i pojedinaca. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>)</p>
</sec>
<sec sec-type="other4">
<title>Mogu&#x0107;i nedostatci i ograni&#x010D;enja klini&#x010D;kih smjernica</title>
<p>Kako klini&#x010D;ke smjernice nastaju iz potrebe, dio preporuka nije rezultat postojanja uvjerljivih visokovrijednih dokaza, ve&#x0107; su rezultat stru&#x010D;nog mi&#x0161;ljenja. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) Slijedom navedenog, mogu biti u krivu. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Nadalje, smjernice ponekad mogu biti dvosmislene te se odluka ne mo&#x017E;e donijeti. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Razina dokaza &#x010D;esto je visoka, a preporuka nedvosmislena. No, istra&#x017E;ivanja koja rezultiraju dokazima visoke kvalitete imaju izrazito homogene skupine ispitanika s vrlo jasno definiranim pitanjima. Bolesnici u klini&#x010D;koj praksi su nehomogena skupina koja nerijetko ne odgovara karakteristikama ispitanika u istra&#x017E;ivanjima. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>) Multicentri&#x010D;na randomizirana i placebo-kontrolirana istra&#x017E;ivanja skupa su i &#x010D;esto su financirana od strane vlasnika proizvoda, &#x0161;to vodi mogu&#x0107;oj pristranosti i sukobu interesa autora. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) Dostupni podatci govore kako je &#x010D;ak 52% autora u sukobu interesa, a u Sjedinjenim Ameri&#x010D;kim Dr&#x017E;avama 80% randomiziranih istra&#x017E;ivanja sponzorirano je privatnim kapitalom. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>, <xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) Kod takvih istra&#x017E;ivanja ishod koji podupire hipotezu prona&#x0111;e se u 98,5% slu&#x010D;ajeva. Omjer &#x0161;ansi za ostvarivanje pozitivnog ishoda ve&#x0107;i je 2,8 puta u odnosu na istra&#x017E;ivanja koja su financirana iz javnih izvora. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Sljede&#x0107;i problem je brzo generiranje novih spoznaja koje ne moraju pratiti promjene u klini&#x010D;kim smjernicama koje zbog toga mogu kaskati. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Preporuke mogu biti a&#x017E;urne, jasno formulirane i potkrijepljene obiljem kvalitetnih dokaza, no mogu postojati nepremostive lokalne prepreke kao &#x0161;to je nepostojanje kadra koji mo&#x017E;e obaviti odre&#x0111;eni zahvat ili medicinske opreme za provo&#x0111;enje dijagnosti&#x010D;kih postupaka. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Nadalje, iako smjernice mogu zadovoljavati sve uvjete kako bi se smatrale valjanima, a u praksi je njihova primjena izvediva, one mogu biti suprotne stavovima bolesnika. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Rad u skladu sa smjernicama mo&#x017E;e pru&#x017E;iti pravnu za&#x0161;titu, pomislili bismo, no postoje slu&#x010D;ajevi gdje su lije&#x010D;nici kritizirani zbog slijepog slije&#x0111;enja smjernica, a neki su i pravno osu&#x0111;eni zbog ignoriranja vlastite klini&#x010D;ke prosudbe. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) Kao posljednja stavka mo&#x017E;e se navesti mi&#x0161;ljenje kako nekriti&#x010D;ko pridr&#x017E;avanje smjernica oduzima slobodu lije&#x010D;nicima, &#x010D;ime oni postaju izvr&#x0161;itelji odluka koje su proizvod razmi&#x0161;ljanja drugih (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Pros and possible cons of clinical practice guidelines</title>
</caption>
<table frame="hsides" rules="groups">
<col width="50.01%"/>
<col width="49.99%"/>
<thead>
<tr>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Prednosti / Pros</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Mogu&#x0107;i nedostatci / Possible cons</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Ujedna&#x010D;avanje zdravstvene skrbi<break/>/ Standardization of healthcare</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Niska razina dokaza koja podupire pojedine preporuke<break/>/ Low level of evidence supporting individual recommendations</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Unaprje&#x0111;enje klini&#x010D;kih ishoda / Improvement of clinical outcomes</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Opre&#x010D;nost preporuka / Contradictory recommendations</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Usmjeravanje znanstvenih napora ka neodgovorenim pitanjima<break/>/ Directing scientific efforts towards unanswered questions</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Pristranost koja proizlazi iz na&#x010D;ina financiranja istra&#x017E;ivanja<break/>/ Bias arising from research funding</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row">Informiranje i osna&#x017E;ivanje polo&#x017E;aja bolesnika<break/>/ Informing and empowering the position of patients</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Sukob interesa autora<break/>/ Conflict of interest among authors</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt" scope="row">Utjecaj na javnu politiku<break/>/ Impact on public policy</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt">Nemogu&#x0107;nost primjene u pojedinim sredinama<break/>/ Inapplicability in certain local settings</td>
</tr>
</tbody></table></table-wrap>
</sec>
<sec sec-type="other5">
<title>Zaklju&#x010D;ak</title>
<p>Klini&#x010D;ke smjernice postale su nezamjenjiv alat u radu klini&#x010D;ara. Unaprijedile su zdravstvenu skrb standardiziraju&#x0107;i metode lije&#x010D;enja koje se temelje na dostupnim dokazima. Navedeno rezultira pobolj&#x0161;anjem klini&#x010D;kih ishoda lije&#x010D;enja uz smanjenje varijabilnosti u lije&#x010D;enju, a istovremeno omogu&#x0107;uje bolje iskori&#x0161;tavanje resursa. (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>, <xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Doprinose kulturi kontinuiranog u&#x010D;enja, &#x010D;ime se stvaraju okolnosti dugoro&#x010D;nog napretka. Me&#x0111;utim, smjernice nisu poplo&#x010D;ena cesta koja vodi ravno k uspjehu. Iako su unaprje&#x0111;ivane kroz povijest preostalo je nekoliko izazova, kao &#x0161;to su sukob interesa autora ili kaskanje a&#x017E;uriranja smjernica za objavama novih spoznaja, koji se moraju svladati. Kreirana su pravila kojima se nastoji ukloniti mogu&#x0107;nost sukoba interesa. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>) Nadalje, izazov nejednakih mogu&#x0107;nosti u smislu pru&#x017E;anja zdravstvene za&#x0161;tite Svjetska gastroenterolo&#x0161;ka organizacija poku&#x0161;ala je prevladati objavom kaskadnih smjernica. Naime, preporuke nisu iste za zemlje koje se nalaze na razli&#x010D;itom stupnju razvoja. Primjerice, zlatni standard za postavljanje dijagnoze celijakije jest pozitivan nalaz serologije uz promjene u patohistolo&#x0161;kom nalazu. U zemljama s vrlo ograni&#x010D;enim resursima serologija je dovoljna za postavljanje dijagnoze. (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>)</p>
<p>Slijedom navedenoga, klini&#x010D;ke smjernice predstavljaju va&#x017E;nu kariku prilikom dono&#x0161;enja odluka, ali kona&#x010D;nu odluku valja donijeti u skladu s duhom medicine temeljene na dokazima koja uz informaciju uzima u obzir klini&#x010D;ku procjenu lije&#x010D;nika te vrijednosti bolesnika. (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>)</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p content-type="fn-title">INFORMACIJE O SUKOBU INTERESA</p>
<p>Autori nisu deklarirali sukob interesa relevantan za ovaj rad.</p>
</fn>
<fn fn-type="financial-disclosure">
<p content-type="fn-title">INFORMACIJA O FINANCIRANJU</p>
<p>Za ovaj &#x010D;lanak nisu primljena financijska sredstva.</p>
</fn>
</fn-group>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="web">Busse R, Klazinga N, Panteli D, Legido-Quigley H, Reichebner C, Ollenschlager G, et al. Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies. European Observatory on Health Systems and Policies [Internet]. 2019. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK549283/">https://www.ncbi.nlm.nih.gov/books/NBK549283/</ext-link>. [Pristupljeno 20. kolovoza 2023.]</mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Billhult</surname><given-names>A</given-names></name><name><surname>Billhult</surname><given-names>T</given-names></name><name><surname>Pallari</surname><given-names>E</given-names></name><name><surname>Lewison</surname><given-names>G</given-names></name></person-group>. <article-title>A new database of the references on international clinical practice guidelines: a facility for the evaluation of clinical research.</article-title> <source>Scientometrics</source>. <year>2020</year>;<volume>122</volume>:<fpage>1221</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-019-03318-2</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="web">Curcic D. Audiobook Sales Statistics. [Interenet]. 2023. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wordsrated.com/audiobook-sales-statistics/">https://wordsrated.com/audiobook-sales-statistics/</ext-link>. [Pristupljeno 24. kolovoza 2023.]</mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkanyi</surname><given-names>L</given-names></name><name><surname>Cornet</surname><given-names>R</given-names></name></person-group>. <article-title>The Interplay of Knowledge Representation with Various Fields of Artificial Intelligence in Medicine.</article-title> <source>Yearb Med Inform</source>. <year>2019</year>;<volume>28</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1055/s-0039-1677899</pub-id><pub-id pub-id-type="pmid">31022748</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kredo</surname><given-names>T</given-names></name><name><surname>Bernhardsson</surname><given-names>S</given-names></name><name><surname>Machingaidze</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Louw</surname><given-names>Q</given-names></name><name><surname>Ochodo</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Guide to clinical practice guidelines: the current state of play.</article-title> <source>Int J Qual Health Care</source>. <year>2016</year>;<volume>28</volume>(<issue>1</issue>):<fpage>122</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/intqhc/mzv115</pub-id><pub-id pub-id-type="pmid">26796486</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forciea</surname><given-names>MA</given-names></name><name><surname>Crandall</surname><given-names>CJ</given-names></name><name><surname>Fitterman</surname><given-names>N</given-names></name><name><surname>Hicks</surname><given-names>LA</given-names></name><name><surname>Horwitch</surname><given-names>CA</given-names></name><name><surname>Maroto</surname><given-names>M</given-names></name><etal/></person-group> <article-title>The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods.</article-title> <source>Ann Intern Med</source>. <year>2019</year>;<volume>170</volume>(<issue>12</issue>):<fpage>863</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.7326/M18-3290</pub-id><pub-id pub-id-type="pmid">31181568</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tebala</surname><given-names>GD</given-names></name></person-group>. <article-title>The Emperor&#x2019;s New Clothes: a Critical Appraisal of Evidence-based Medicine.</article-title> <source>Int J Med Sci</source>. <year>2018</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1397</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.25869</pub-id><pub-id pub-id-type="pmid">30275768</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisz</surname><given-names>G</given-names></name><name><surname>Cambrosio</surname><given-names>A</given-names></name><name><surname>Keating</surname><given-names>P</given-names></name><name><surname>Knaapen</surname><given-names>L</given-names></name><name><surname>Schlich</surname><given-names>T</given-names></name><name><surname>Tournay</surname><given-names>VJ</given-names></name></person-group>. <article-title>The emergence of clinical practice guidelines.</article-title> <source>Milbank Q</source>. <year>2007</year>;<volume>85</volume>(<issue>4</issue>):<fpage>691</fpage>&#x2013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-0009.2007.00505.x</pub-id><pub-id pub-id-type="pmid">18070334</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="book">Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E. ur. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011, str. 29&#x2013;204.</mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shekelle</surname><given-names>P</given-names></name><name><surname>Woolf</surname><given-names>S</given-names></name><name><surname>Grimshaw</surname><given-names>JM</given-names></name><name><surname>Sch&#x00FC;nemann</surname><given-names>HJ</given-names></name><name><surname>Eccles</surname><given-names>MP</given-names></name></person-group>. <article-title>Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development.</article-title> <source>Implement Sci</source>. <year>2012</year>;<volume>7</volume>:<fpage>62</fpage>. <pub-id pub-id-type="doi">10.1186/1748-5908-7-62</pub-id><pub-id pub-id-type="pmid">22762242</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollon</surname><given-names>SD</given-names></name><name><surname>Are&#x00E1;n</surname><given-names>PA</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>Crawford</surname><given-names>KA</given-names></name><name><surname>Kivlahan</surname><given-names>DR</given-names></name><name><surname>Magnavita</surname><given-names>JJ</given-names></name><etal/></person-group> <article-title>Development of clinical practice guidelines.</article-title> <source>Annu Rev Clin Psychol</source>. <year>2014</year>;<volume>10</volume>:<fpage>213</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-clinpsy-050212-185529</pub-id><pub-id pub-id-type="pmid">24679179</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>JVA</given-names></name><name><surname>Arancibia</surname><given-names>M</given-names></name><name><surname>Meza</surname><given-names>N</given-names></name><name><surname>Madrid</surname><given-names>E</given-names></name><name><surname>Kopitowski</surname><given-names>K</given-names></name></person-group>. <article-title>Clinical practice guidelines: Concepts, limitations and challenges.</article-title> <source>Medwave</source>. <year>2020</year>;<volume>20</volume>(<issue>3</issue>):<elocation-id>e7887</elocation-id>. <pub-id pub-id-type="doi">10.5867/medwave.2020.03.7887</pub-id><pub-id pub-id-type="pmid">32428925</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Zhai</surname><given-names>Z</given-names></name><etal/><collab>TERM Working Group</collab></person-group>. <article-title>Publishing clinical prActice GuidelinEs (PAGE): Recommendations from editors and reviewers.</article-title> <source>J Evid Based Med</source>. <year>2022</year>;<volume>15</volume>(<issue>2</issue>):<fpage>136</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/jebm.12479</pub-id><pub-id pub-id-type="pmid">35768995</pub-id></mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="book">Straus SE. Evidence-Based Medicine: How to Practice and Teach Ebm. 5. izd. Edinburgh: Elsevier/Churchill Livingstone; 2019, str. 22.</mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>J</given-names></name><name><surname>Patkar</surname><given-names>V</given-names></name><name><surname>Chronakis</surname><given-names>I</given-names></name><name><surname>Begent</surname><given-names>R</given-names></name></person-group>. <article-title>From practice guidelines to clinical decision support: closing the loop.</article-title> <source>J R Soc Med</source>. <year>2009</year>;<volume>102</volume>(<issue>11</issue>):<fpage>464</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1258/jrsm.2009.090010</pub-id><pub-id pub-id-type="pmid">19875535</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahtsevani</surname><given-names>C</given-names></name><name><surname>Ud&#x00E9;n</surname><given-names>G</given-names></name><name><surname>Willman</surname><given-names>A</given-names></name></person-group>. <article-title>Outcomes of evidence-based clinical practice guidelines: a systematic review.</article-title> <source>Int J Technol Assess Health Care</source>. <year>2004</year>;<volume>20</volume>(<issue>4</issue>):<fpage>427</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1017/S026646230400131X</pub-id><pub-id pub-id-type="pmid">15609791</pub-id></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>CC</given-names></name></person-group>. <article-title>Pros and cons of clinical practice based on guidelines.</article-title> <source>Hong Kong Med J</source>. <year>2018</year>;<volume>24</volume>(<issue>5</issue>):<fpage>440</fpage>&#x2013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.12809/hkmj185083</pub-id><pub-id pub-id-type="pmid">30318475</pub-id></mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>SH</given-names></name><name><surname>Grol</surname><given-names>R</given-names></name><name><surname>Hutchinson</surname><given-names>A</given-names></name><name><surname>Eccles</surname><given-names>M</given-names></name><name><surname>Grimshaw</surname><given-names>J</given-names></name></person-group>. <article-title>Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.</article-title> <source>BMJ</source>. <year>1999</year>;<volume>318</volume>(<issue>7182</issue>):<fpage>527</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.318.7182.527</pub-id><pub-id pub-id-type="pmid">10024268</pub-id></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brichko</surname><given-names>L</given-names></name><name><surname>Mitra</surname><given-names>B</given-names></name><name><surname>Cameron</surname><given-names>P</given-names></name></person-group>. <article-title>When guidelines guide us to harm.</article-title> <source>Emerg Med Australas</source>. <year>2018</year>;<volume>30</volume>(<issue>6</issue>):<fpage>740</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/1742-6723.13189</pub-id><pub-id pub-id-type="pmid">30456792</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murad</surname><given-names>MH</given-names></name></person-group>. <article-title>Clinical Practice Guidelines: A Primer on Development and Dissemination.</article-title> <source>Mayo Clin Proc</source>. <year>2017</year>;<volume>92</volume>(<issue>3</issue>):<fpage>423</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2017.01.001</pub-id><pub-id pub-id-type="pmid">28259229</pub-id></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>JC</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><name><surname>Corazza</surname><given-names>GR</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Farthing</surname><given-names>M</given-names></name><name><surname>Catassi</surname><given-names>C</given-names></name><etal/></person-group> <article-title>World Gastroenterology Organization. World Gastroenterology Organisation global guidelines on celiac disease.</article-title> <source>J Clin Gastroenterol</source>. <year>2013</year>;<volume>47</volume>(<issue>2</issue>):<fpage>121</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/MCG.0b013e31827a6f83</pub-id><pub-id pub-id-type="pmid">23314668</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
